Skip to main content

Table 10 Association between lipodystrophy and the metabolic syndrome and its individual components in women

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

  Modelo 1
OR (95% CI)
Modelo 2
OR (95% CI)
Modelo3
OR (95% CI)
MS ATP III 1.074 (0.501-2.303) 0.763 (0.298-1.952) 2.730 (0.810-9.194)
High waist circumference 0.394 (0.178-0.869) 0.306 (0.118-0.796) --
Hypertriglyceridemia 4.091 (1.557-10.750) 3.091 (1.063-8.989) 5.917 (1.50-23.349)
Low HDL cholesterol 2.765 (1.174-6.513) 2.308 (0.885-6.020) 3.990 (1.252-12.716)
High fasting glucose 0.713 (0.298-1.701) 0.560 (0.204-1.534) 0.758 (0.240-2.390)
High blood pressure 0.826 (0.371-1.839) 0.511 (0.177-1.474) 0.917 (0.273-3.078)
MS IDF 1.613 (0.742-3.507) 1.461 (0.572-3.736) 5.290 (1.502-18.635)
High waist circumference 0.543 (0.212-1.393) 0.385 (0.127-1.164) --
Hypertriglyceridemia 4.091 (1.557-10.750) 3.091 (1.063-8.989) 5.917 (1.500-23.349)
Low HDL cholesterol 2.765 (1.174-6.513) 2.308 (0.885-6.020) 3.990 (1.252-12.716)
High fasting glucose 0.713 (0.298-1.701) 0.560 (0.204-1.534) 0.758 (0.240-2.390)
High blood pressure 0.826 (0.371-1.839) 0.511 (0.177-1.474) 0.917 (0.273-3.078)
  1. Model 1 - OR crude
  2. Model 2 - OR adjusted for gender, age and cART
  3. Model 3 - OR adjusted for gender, age, duration of cART and BMI